ChienYeh Biotech Investment Holding Co., Ltd. Announces Q1 2026 EPS of 0.13 NT Dollars
NQ Score
0/100
N1 Content Completeness
0
Key facts
- ChienYeh Biotech Investment Holding Co., Ltd. Announces Q1 2026 EPS of 0.13 NT Dollars
- ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.
- Source: TWSE
- Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
Direct answer
ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.
- Citation
- ChienYeh Biotech Investment Holding Co., Ltd. Announces Q1 2026 EPS of 0.13 NT Dollars (Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)), TWSE
- Source
- TWSE
- Date
- Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.
AI Analysis
Frequently Asked Questions
- Q: What are the key facts in this article?
- A: ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.
- Q: What is the direct answer?
- A: ChienYeh Biotech Investment Holding Co., Ltd. reported its Q1 2026 financial results, with an EPS of 0.13 NT Dollars, operating revenue of 1.16 billion NT Dollars, and net profit after tax of 0.36 billion NT Dollars. This performance is indicative of the biotech and medical industry.
- Q: What is the source and date?
- A: Source: https://openapi.twse.com.tw/financial/twse-fin-4164-2026Q1 | Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)